Home
  >  
Section 33
  >  
Chapter 32,956

Principles of drug disposition and therapy in neonates infants and children

Levin, R.H.

Rudolph, A M (Ed ) Rudolph's Pediatrics, 19th Edition Xlii+2111p Appleton And Lange East Norwalk, Connecticut, Usa; Prentice-Hall International (Uk) Ltd : London, England, Uk Illus Maps 859-862

1991

Accession: 032955440
Download citation:  
Text
  |  
BibTeX
  |  
RIS

Full Text Article emailed within 1 workday: $29.90




Related References

Mirkin, B.L. 1977: Principles of drug disposition and therapy in infants and children Rudolph, Abraham M (Ed ) Pediatrics 16th Ed Xxx+2198p Illus Appleton-Century-Crofts: New York, N Y , Usa ISBN 0-8385-7794-6: 843-852
Kearns, G.L.; Abdel-Rahman, S.M.; Alander, S.W.; Blowey, D.L.; Leeder, J.Steven.; Kauffman, R.E. 2003: Developmental pharmacology--drug disposition, action, and therapy in infants and children New England Journal of Medicine 349(12): 1157-1167
Reed, M.D. 1996: The ontogeny of drug disposition : Focus on drug absorption, distribution, and excretion : Drug development for infants and children : Rescuing the therapeutic orphan Drug Inf. J 30(4): 1129-1134
Hines, R.N. 2013: Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children International Journal of Pharmaceutics 452(1-2): 3-7
Wildschut, E.D.; van Saet, A.; Pokorna, P.; Ahsman, M.J.; Van den Anker, J.N.; Tibboel, D. 2012: The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children Pediatric Clinics of North America 59(5): 1183-1204
Brown, R.D.; Campoli-Richards, D.M. 1989: Antimicrobial therapy in neonates, infants and children Clinical Pharmacokinetics 17(Suppl): 105-115
Steurer, M.A.; Berger, T.M. 2011: Infusion therapy for neonates, infants and children Der Anaesthesist 60(1): 10-22
De Wildt, S.N. 2011: Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children Expert Opinion on Drug Metabolism and Toxicology 7(8): 935-948
Rodieux, F.; Wilbaux, M.; van den Anker, J.N.; Pfister, M. 2015: Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children Clinical Pharmacokinetics 54(12): 1183-1204
Kearns, G.L.; Robinson, P.; Adcock, K.; Wilson Costello, D.; Knight, G.; Zhou, H.H.; Ward, R.; Van Den Anker, J.; Ppru Network 2001: Cisapride disposition in neonates and infants Clinical Pharmacology and Therapeutics 69(2): P31
Mcrorie, T. 1996: Quality drug therapy in children : Formulations and delivery : Drug development for infants and children : Rescuing the therapeutic orphan Drug Inf. J 30(4): 1173-1177
Zucchi, M. 1970: On the current possibilities of drug therapy of drug therapy of abnormalities of behavior of the character type in infants and children Minerva Medica 61(82): 4542-4550
Sümpelmann, R. 2011: On water, salt and more … infusion therapy for neonates, infants and children Der Anaesthesist 60(1): 8-9
Marcadis, M.L.; Kraus, D.M.; Chow Tung, E.; Young, S.L.; Mcculloch, K.M.; Fischer, J.H. 1991: Effects of maturation on gentamicin disposition in neonates and infants Pharmacotherapy 11(3): 269
Reed, M.D.; Gooch, W.M.; Minton, S.D.; Tanaka-Kido, J.; Santos, J.I.; Yamashita, T.S.; Blumer, J.L. 1991: Ceftizoxime disposition in neonates and infants during the first six months of life Dicp: the Annals of PharmacoTherapy 25(4): 344-347